Michelle Werner
Directeur/Bestuurslid bij OMEGA THERAPEUTICS, INC.
Vermogen: - $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Michelle Werner
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
University of Pennsylvania
306
| College/University | Other Consumer Services | 306 |
| Public Company | Pharmaceuticals: Major | 181 | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.
173
| Private Company | Investment Managers | 173 |
London Business School
140
| College/University | Other Consumer Services | 140 |
| Public Company | Pharmaceuticals: Major | 70 | |
| Public Company | Biotechnology | 18 | |
Alltrna
 Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius.
3
| Holding Company | Biotechnology | 3 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michelle Werner via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Massachusetts Institute of Technology | College/University | Director/Board Member Corporate Officer/Principal Graduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Chairman | |
| Yale University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Chairman Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Founder Chief Executive Officer Director/Board Member | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Director/Board Member Founder | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree Corporate Officer/Principal | |
| Princeton University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| RUBIUS THERAPEUTICS | Biotechnology | Founder Director/Board Member President Founder | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| MODERNA, INC. | Biotechnology | Director/Board Member Director/Board Member Founder Director/Board Member | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Founder Chief Administrative Officer | |
| BG MEDICINE, INC. | Medical Specialties | Founder Director of Finance/CFO Chief Operating Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Flagship Labs 89, Inc. | Biotechnology | Founder Chief Executive Officer Founder | |
Montai Health, Inc.
 Montai Health, Inc. Packaged SoftwareTechnology Services Montai Health, Inc. is a company that is using its pioneering AI-powered Conecta™ platform to develop Anthromolecule™ medicines that will treat and preempt chronic diseases to improve health outcomes for the 2 billion people worldwide living with these diseases. The company is based in Cambridge, MA. Montai Health is unlocking the potential of Anthromolecule™ chemistry with its pioneering AI-powered Conecta™ platform to develop breakthrough small-molecule medicines that will treat and preempt chronic diseases to improve health outcomes for the two billion people worldwide living with these diseases. The company was founded by Hok Hei Tam, Michael Wong, David Kolesky, Mary Margaret Hastings Georgiadis. Mary Margaret Hastings Georgiadis has been the CEO since incorporation. | Packaged Software | Director/Board Member Founder Founder | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Biotechnology | Founder Director/Board Member Chief Executive Officer | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| SERES THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member Chairman | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Inari Agriculture, Inc.
 Inari Agriculture, Inc. BiotechnologyHealth Technology Inari Agriculture, Inc. engages biotechnology research and development. It specializes in plant breeding technology. The company was founded by David Berry, Ignacio Martinez, George Church, and Steve Jacobsen in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Founder Director/Board Member | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Founder Director/Board Member | |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Graduate Degree Graduate Degree | |
| Georgia Institute of Technology | College/University | Undergraduate Degree Graduate Degree | |
YourEncore, Inc.
 YourEncore, Inc. Internet Software/ServicesTechnology Services YourEncore, Inc. provides business support services. It offers business solutions for the research, development, and commercialization needs of clients across the pharmaceutical, biotechnology, consumer care, food, and aerospace industries. The company was founded by Bradley W. Lawson, John H. Barnard and Timothy J. Tichenor in 2003 and is headquartered in Indianapolis, IN. | Internet Software/Services | Director/Board Member Director/Board Member | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
Affinnova, Inc.
 Affinnova, Inc. Information Technology ServicesTechnology Services Affinnova, Inc. is a global marketing technology, which provides sales solutions for large and mid-sized enterprises. The company was founded by Kamal M. Malek in 2000 and is headquartered in New York, NY. | Information Technology Services | Founder Director of Finance/CFO | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member Founder | |
LS Dissolution, Inc.
 LS Dissolution, Inc. Chemicals: Major DiversifiedProcess Industries LS Dissolution, Inc. engages in the production of petroleum replacement products and industrial chemicals. It offers chemical and fuel products. The company was founded by George M. Church, Christopher Somerville, Noubar B. Afeyan and Jay D. Keasling in 2005 and is headquartered in South San Francisco, CA. | Chemicals: Major Diversified | Founder Founder | |
Empress Therapeutics, Inc.
 Empress Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Empress Therapeutics, Inc. is a company that was founded by Flagship Pioneering in 2020. The company is based in Cambridge, MA. Empress Therapeutics generates medicines quickly by using the chemistry inside the human body. The company uses the Empress Chemilogics™ platform to create first- or oral medicines for a broad range of diseases quickly, predictably, and cost-effectively. The platform uses novel insights that connect the lines of code in DNA with drug-like chemistry made in the human body. Jason Park is the founder of the company and has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Verenigd Koninkrijk | 4 |
| Denemarken | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 15 |
| Commercial Services | 5 |
| Technology Services | 4 |
| Process Industries | 3 |
Operationeel
| Director/Board Member | 410 |
| Corporate Officer/Principal | 167 |
| Independent Dir/Board Member | 111 |
| Chairman | 106 |
| Founder | 102 |
Sterkste connecties
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| George Church | 45 |
| Michael Rosenblatt | 31 |
| Ed Kania | 31 |
| John Mendlein | 27 |
| Theo Melas-Kyriazi | 26 |
| Sherilyn McCoy | 26 |
| Philip Broadley | 24 |
| James Cornelius | 23 |
| Brian Daniels | 20 |
| Thomas Lynch | 20 |
| Ann Cairns | 20 |
| Alan J. Lacy | 19 |
| Mary Szela | 19 |
| Luke Beshar | 19 |
- Beurs
- Insiders
- Michelle Werner
- Bedrijfsconnecties
